Quantitative differences in the immunomodulatory effects of Rebif and Avonex in IFN-β 1a treated multiple sclerosis patients
about
Less Frequent and Less Severe Flu-Like Syndrome in Interferon Beta-1a Treated Multiple Sclerosis Patients with at Least One Allele Bearing the G>C Polymorphism at Position -174 of the IL-6 Promoter Gene.Efficacy of fish oil on serum of TNF α , IL-1 β , and IL-6 oxidative stress markers in multiple sclerosis treated with interferon beta-1b.Dimethyl Fumarate Therapy Significantly Improves the Responsiveness of T Cells in Multiple Sclerosis Patients for Immunoregulation by Regulatory T Cells.The C-C Chemokines CCL17 and CCL22 and Their Receptor CCR4 in CNS Autoimmunity.Improving Immunotherapy Through Glycodesign
P2860
Quantitative differences in the immunomodulatory effects of Rebif and Avonex in IFN-β 1a treated multiple sclerosis patients
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Quantitative differences in th ...... ed multiple sclerosis patients
@ast
Quantitative differences in th ...... ed multiple sclerosis patients
@en
type
label
Quantitative differences in th ...... ed multiple sclerosis patients
@ast
Quantitative differences in th ...... ed multiple sclerosis patients
@en
prefLabel
Quantitative differences in th ...... ed multiple sclerosis patients
@ast
Quantitative differences in th ...... ed multiple sclerosis patients
@en
P2093
P2860
P1476
Quantitative differences in th ...... ed multiple sclerosis patients
@en
P2093
Burk Jubelt
Cornelia Mihai
George P Christophi
Jennifer A Christophi
Luis J Mejico
Paul T Massa
Ross C Gruber
P2860
P356
10.1016/J.JNS.2011.05.024
P577
2011-06-11T00:00:00Z